Tag Archives: FIRST_PUBLISH_HEADLINE | Gilead Sciences to Pay $ 300 Million for Almost Half of Tizona

Gilead Sciences Inc. GILD, -1.15% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …

Gilead Sciences Inc. GILD, -1.29% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …